Clinical Trial Update: A Trial Evaluating the Safety & Efficacy of Intra-Tumoral Ipilimumab in Combination With Intra-venous Nivolumab in Patients With Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating intra-tumoral ipilimumab plus intravenous nivolumab in metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iv Melanoma

Drugs mentioned

• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: Gustave Roussy, Cancer Campus, Grand Paris | Conditions: Stage III/IV Melanoma | Phase 1, Phase 2 | Status: COMPLETED